Health Care · NYSE: UNH
UnitedHealth: how the business works
UnitedHealth Group runs the UnitedHealthcare health insurer and the Optum care, data and drug-benefit businesses, with revenue of $447.6 billion in FY2025.
By Hardik Bhandare · Checked against filings: . Editorial policy. Corrections
Follow UnitedHealth
Email me when UnitedHealth's page is updated after earnings.
We'll send a confirmation email first. See our privacy policy.
UnitedHealth Group Incorporated · Eden Prairie, Minnesota
Updated for Q3 FY2026 · checked
- Revenue, FY2025
- $447.6B
- Earnings from operations, FY2025
- $19.0B
- Net earnings, FY2025
- $12.1B
- People with UnitedHealthcare medical coverage, Sep 30, 2026
- 48.3 million
- Employees, Dec 31, 2025
- More than 390,000
The short version
UnitedHealth in 5 points
1 · What it sells
UnitedHealth Group sells health coverage through UnitedHealthcare, which covered 48.3 million people at Sep 30, 2026, and care, data and drug-benefit services through Optum, with revenue of $447.6 billion in FY2025.
2 · Who pays it
In FY2025, UnitedHealthcare's Medicare & Retirement plans brought in 38.3% of revenue, Optum's outside customers 22.5%, Community & State (Medicaid) 21.1%, Employer & Individual 17.7%, and Optum's investment income 0.4%.
3 · What it keeps from $100
Of every $100 that came in during FY2025, UnitedHealth kept $2.69 as net earnings after one-off Q4 charges including $2.5 billion of restructuring and other costs, while earnings from operations were $4.24 per $100 as reported and $4.85 on its adjusted measure.
4 · Where the operating profit comes from
FY2025 earnings from operations were $9.4 billion at UnitedHealthcare, $7.2 billion at Optum Rx and $2.6 billion at Optum Insight, while Optum Health lost $278 million after $1.7 billion of restructuring and other charges.
5 · The one thing to watch
The medical care ratio was 88.4% in Q3 FY2026, against 89.9% a year earlier, and it included $610 million of favorable reserve development.
Sources: From UnitedHealth's FY2025 10-K, its Q3 FY2026 10-Q and its Q4 FY2025 and Q3 FY2026 earnings releases · checked
See the full receipt and the management scorecard below
01Where the money goes · FY2025
Where does $100 of UnitedHealth's money go?
UnitedHealth · FY2025
Receipt for every $100
| Medical costs (care paid for members) | $70.2 |
|---|---|
| Operating costs | $13.3 |
| Cost of products sold (mostly Optum Rx drugs) | $11.3 |
| Depreciation and amortization | $1.0 |
| Interest and loss on selling subsidiaries | $0.9 |
| Income tax | $0.4 |
| Noncontrolling holders' share | $0.2 |
| Kept as net earnings | $2.7 |
| Total | $100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.
How this is worked out
Cityfort calculation from the FY2025 10-K: each line ÷ revenue of $447.6 billion × 100. Net earnings of $2.69 per $100 include Q4 FY2025 charges: $2.5 billion of restructuring and other costs and a $799 million reserve on cyberattack loans, partly offset by a $568 million net portfolio gain. Earnings from operations were $4.24 per $100 as reported, and $4.85 on the company's adjusted measure (Cityfort calculation from the FY2025 10-K and the Q4 FY2025 earnings release).
Each week: one company explained in 5 points, picked by earnings date.
Free, no tips, unsubscribe anytime.
We'll send a confirmation email. See our privacy policy.
02The business in one line
What does UnitedHealth do?
Employers, people, states and the federal government pay UnitedHealth premiums and fees for health coverage, care and drug benefits; most of that goes on members' medical bills, and $2.69 of every $100 that came in during FY2025 was left as net earnings.
- UnitedHealth Group has two businesses: UnitedHealthcare (health insurance) and Optum (doctors and care, health data and technology, and pharmacy benefits).
- Premiums from CMS, the federal agency that runs Medicare and Medicaid, were 44% of FY2025 revenue.
03Who pays it
Who pays UnitedHealth?
Medicare & Retirement members and CMS
38%
of revenue
Premiums and fees for UnitedHealthcare's Medicare plans: $171.3 billion, 38.3% of FY2025 revenue (Cityfort calculation from the FY2025 10-K). UnitedHealthcare's business figures include its investment income.
Optum's outside customers
23%
of revenue
Health plans, employers, care providers and others outside the group that buy Optum's care, data and drug-benefit services: $100.9 billion, 22.5% of revenue.
States and CMS for Medicaid
21%
of revenue
Community & State premiums for Medicaid plans: $94.4 billion, 21.1% of revenue. The company does not split this between state and federal money.
Employers and individuals
18%
of revenue
Employer & Individual premiums and fees: $79.2 billion, 17.7% of revenue, including $3.3 billion from the global business.
Optum investment income
0%
of revenue
Not a customer: Optum's investment and other income of $1.7 billion, 0.4% of revenue.
- Medicare & Retirement members and CMS38%
- Optum's outside customers23%
- States and CMS for Medicaid21%
- Employers and individuals18%
- Optum investment income0%
Customer concentration
Premium revenue from CMS, the federal Medicare and Medicaid agency, was 44% of UnitedHealth's FY2025 revenue, against 40% in FY2024 and FY2023. Most of it comes through Medicare & Retirement, the rest through Community & State. No other single customer is disclosed as material.
- Largest customer
- 44%
04Why it makes money
Why does UnitedHealth make money?
UnitedHealth keeps a thin slice of $447.6 billion of yearly revenue, so a small change in members' medical costs moves profit a lot.
In FY2025, medical costs took $70.16 of every $100 that came in. The medical care ratio (medical costs as a share of premiums) rose from 83.2% in FY2023 to 89.1% in FY2025. One point of that ratio on FY2025 premiums of $352.2 billion is about $3.5 billion (Cityfort calculation from the FY2025 10-K).
Earnings from operations per $100 of revenue
$8.3$4.2
FY2021 to FY2025
- Employers, people, states and CMS pay premiums, set a year ahead
- UnitedHealthcare pays members' medical and drug bills
- Optum Health, Optum Rx and Optum Insight earn fees for care, drugs and services, much of it from UnitedHealthcare
- Medical costs against premiums decide most of the margin
- Outside Optum customers add revenue on the same systems
- What is left pays interest, dividends, buybacks and acquisitions
↺ Step 6 feeds back into step 1.
05Business segments · FY2025
Which businesses make up UnitedHealth?
UnitedHealthcare
56%Health insurance. Earnings from operations were $9.4 billion, a 2.7% margin, down from $15.6 billion in FY2024. Revenue shares here are of $621.0 billion of segment revenue, before $173.4 billion of business between segments is removed (Cityfort calculation from the FY2025 10-K).
Revenue $344.9B · Operating profit $9.4B
Optum Rx
25%Pharmacy benefits. Earnings from operations were $7.2 billion, including a $1.5 billion net gain from Q4 FY2025 portfolio actions, among them a gain on deconsolidating a business.
Revenue $154.7B · Operating profit $7.2B
Optum Health
16%Care delivery. It lost $278 million from operations after $1.7 billion of restructuring and other charges and $821 million of portfolio losses in Q4 FY2025, against $7.8 billion of earnings in FY2024.
Revenue $102.0B · Operating profit −$278M
Optum Insight
3%Data, technology and services. Earnings from operations were $2.6 billion, a 13.5% margin, after the $799 million cyberattack loan reserve. On Jan 1, 2026, Optum Financial moved here from Optum Health; FY2021 to FY2025 figures are as first reported.
Revenue $19.4B · Operating profit $2.6B
How the mix changed
- UnitedHealthcare
- Optum Rx
- Optum Health
- Optum Insight
Revenue by segment, FY2021 to FY2025.
US$
See the numbers
06The numbers · Consolidated · US$
How has UnitedHealth done?
Revenue
$447.6BFY2025
Revenue rose every year, from $287.6 billion in FY2021 to $447.6 billion in FY2025, and was $112.7 billion in Q3 FY2026, 0.4% lower than a year earlier.
US$
See the numbers
Net profit
$12.1BFY2025
Net earnings fell from $22.4 billion in FY2023 to $12.1 billion in FY2025, after an $8.3 billion loss on selling South American units in FY2024 and Q4 FY2025 charges that left that quarter at $10 million.
US$
See the numbers
Profit kept per $100 of revenue
$2.7FY2025
Net earnings per $100 of revenue fell from $6.0 in FY2023 to $2.7 in FY2025, as the medical care ratio rose from 83.2% to 89.1%.
$ of profit per $100 of revenue (net margin)
See the numbers
Free cash flow
$16.1BFY2025
Free cash flow, a Cityfort calculation from the FY2023 and FY2025 10-Ks (cash from operations minus spending on property, equipment and software), fell from $25.7 billion in FY2023 to $16.1 billion in FY2025.
US$ · cash from operations minus spending on plants and equipment
See the numbers
See all yearly numbers
EBITDA here = operating income plus depreciation and amortization (from the cash flow statement). Fiscal years are the company's own (December 31. UnitedHealth's fiscal year matches the calendar year: FY2025 ended Dec 31, 2025, and Q3 FY2026 ended Sep 30, 2026.). Net profit is the share belonging to the company's owners. Total net income differs from net profit to the company's owners: Includes Q4 FY2025 restructuring and other charges of $2.5 billion and a $799 million cyberattack loan reserve. Total net earnings include the share of noncontrolling interests.
Download UnitedHealth's yearly and quarterly numbers (CSV, with source ids)
Learn: Stock-based compensation and dilution: pay that becomes shares
Sources (8)
- Form 10-K, fiscal year 2023 (ended Dec 31, 2023)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Q3 FY2025 earnings release (Form 8-K, Exhibit 99.1, Oct 28, 2025)
- Q3 FY2024 earnings release (Form 8-K, Exhibit 99.1, Oct 15, 2024)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Q1 FY2026 earnings release (Form 8-K, Exhibit 99.1, Apr 21, 2026)
- Q2 FY2026 earnings release (Form 8-K, Exhibit 99.1, Jul 16, 2026)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
07Who runs it
Who runs UnitedHealth, and did they deliver?
Stephen J. Hemsley
Chair and Chief Executive Officer · since 2025
Became CEO on May 12, 2025, when Andrew Witty stepped down (announced May 13); he was CEO from 2006 to 2017 and was already Chair. His pay: $1 million salary, no cash bonus and a one-time $60 million stock option grant that vests after three years. In February 2026 the option was amended to require him to keep the net shares until May 14, 2030.
Wayne DeVeydt
Chief Financial Officer · since 2025
CFO since Sep 2, 2025, announced on Jul 31, 2025. He succeeded John Rex.
Patrick Conway
Chief Executive Officer, Optum · since 2025
Named Optum CEO on Apr 29, 2025, effective May 6, 2025.
F. William McNabb III
Lead Independent Director · since 2025
Lead independent director since August 2025, succeeding Michele Hooper. He is a former chair and CEO of Vanguard.
What they said, and what happened
1 missed · 1 partly delivered · 5 too early to tell
Said on Jan 16, 2025
UnitedHealth guided on Jan 16, 2025 to 2025 revenue of $450 billion to $455 billion, GAAP EPS of $28.15 to $28.65 and adjusted EPS of $29.50 to $30.00.
MissedWhat happened
The guide was cut on Apr 17, 2025 and suspended on May 13, 2025. FY2025 revenue was $447.6 billion, GAAP EPS $13.23 and adjusted EPS $16.35.
Said on Jul 29, 2025
UnitedHealth guided on Jul 29, 2025 to 2025 GAAP EPS of at least $14.65 and adjusted EPS of at least $16.00; on Oct 28, 2025 it raised these to at least $14.90 and $16.25.
Partly deliveredWhat happened
Adjusted EPS was $16.35, above the guide. GAAP EPS was $13.23, below it, after Q4 charges the adjusted measure leaves out.
Said on May 13, 2025
When it changed CEO on May 13, 2025, UnitedHealth said it expects to return to growth in 2026.
Too early to tellWhat happened
In the first nine months of 2026, GAAP EPS was $17.50 against $13.21 a year earlier, and revenue was 0.6% higher. Full-year results are not yet reported.
Said on Jan 27, 2026
UnitedHealth guided on Jan 27, 2026 to 2026 revenue above $439.0 billion, GAAP EPS above $17.10 and adjusted EPS above $17.75.
Too early to tellWhat happened
The EPS guide was raised three times, to at least $19.50 GAAP and at least $20.50 adjusted on Oct 13, 2026.
Said on Jan 27, 2026
Management said on Jan 27, 2026 that it expects operating cost reductions of nearly $1 billion in 2026.
Too early to tellWhat happened
The operating cost ratio was 12.8% in Q3 FY2026, against 13.5% a year earlier. The company has not reported the dollar savings.
Said on Jan 27, 2026
Management said on Jan 27, 2026 that UnitedHealthcare's membership would shrink by 2.3 million to 2.8 million in 2026, including 1.3 million to 1.4 million in Medicare Advantage.
Too early to tellWhat happened
By Sep 30, 2026, membership was down 1.46 million, including 840,000 in Medicare Advantage.
Said on Oct 13, 2026
Management said on Oct 13, 2026 that the debt-to-capital ratio would approach 40% by year-end.
Too early to tellWhat happened
It was 41.7% at Sep 30, 2026.
Sources (15)
- 2026 proxy statement (DEF 14A)
- Form 8-K, Items 5.02 and 7.01: CEO transition, 2025 outlook suspended (with Exhibit 99.1)
- Form 8-K, Item 5.02: CEO stock option amended (holding requirement)
- Form 8-K, Item 5.02: CFO appointment (Exhibit 99.1, Jul 31, 2025)
- Form 8-K, Item 5.02: Optum CEO appointment
- Q4 and full-year FY2024 earnings release (Form 8-K, Exhibit 99.1, Jan 16, 2025)
- Q1 FY2025 earnings release (Form 8-K, Exhibit 99.1, Apr 17, 2025)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Q2 FY2025 earnings release (Form 8-K, Exhibit 99.1, Jul 29, 2025)
- Q3 FY2025 earnings release (Form 8-K, Exhibit 99.1, Oct 28, 2025)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Q4 FY2025 earnings call prepared remarks (Jan 27, 2026; no Q&A)
- Q2 FY2026 earnings release (Form 8-K, Exhibit 99.1, Jul 16, 2026)
- Q1 FY2026 earnings release (Form 8-K, Exhibit 99.1, Apr 21, 2026)
- Q3 FY2026 earnings call prepared remarks (Oct 13, 2026; no Q&A)
08What could go wrong
What could go wrong for UnitedHealth?
- Pricing
Medical costs above premiums
Premiums are set in advance, so higher medical use hurts. The medical care ratio rose from 82.0% in FY2022 to 89.1% in FY2025. The 10-K names failing to estimate, price for and manage medical costs as a risk.
Watch The medical care ratio each quarter: 88.4% in Q3 FY2026, including $610 million of favorable reserve development.
- Regulation
Government programs and payment rates
CMS premiums were 44% of FY2025 revenue. Funding, risk adjustment, audits of Medicare Advantage payments and star ratings all affect what the company is paid. The Q3 FY2026 10-Q says Medicare Advantage funding continues to be pressured.
Watch CMS payment rates for 2027 and Medicare Advantage membership: 7.6 million at Sep 30, 2026.
- Legal
Investigations and lawsuits
The company said on Jul 24, 2025 that it had begun complying with formal criminal and civil requests from the DOJ about its Medicare participation. A False Claims Act case on risk adjustment, filed by a whistleblower in 2011 and pursued by the DOJ from Feb 14, 2017, is unresolved, and the IRS has proposed tax adjustments the company disputes.
Watch The legal note in each 10-Q and 10-K, and any 8-K on the DOJ requests.
- Technology
Cyberattacks and data
The February 2024 Change Healthcare attack led to $9.0 billion of loans to care providers in 2024, $2.2 billion of direct response costs that year and a $799 million loan reserve in Q4 FY2025.
Watch Cyberattack costs and loan repayments in each 10-Q.
- Demand
Medicaid rates and members
The FY2025 10-K calls some Medicaid rates insufficient and notes eligibility losses and an exit from one state in 2026. Medicaid members fell from 7.4 million at Dec 31, 2025 to 6.7 million at Sep 30, 2026.
Watch Community & State revenue and Medicaid membership each quarter.
- Other
Goodwill write-downs
Goodwill was $113.0 billion at Sep 30, 2026, 36% of total assets. The 10-K says an impairment could reduce equity and affect credit ratings.
Watch The goodwill note in each 10-K and 10-Q.
- Debt
Debt and credit ratings
Total debt was $74.3 billion at Sep 30, 2026, and interest cost $4.0 billion in FY2025. Moody's, S&P and Fitch outlooks were stable at Dec 31, 2024 and negative at Sep 30, 2026, as stated by the company. A.M. Best moved from A to A-.
Watch Debt-to-capital (41.7% at Sep 30, 2026) and any rating change in each 10-Q.
- Execution
New leadership
The CEO changed in May 2025, the Optum CEO in May 2025 and the CFO in September 2025. The 10-K names keeping key employees and succession as a risk.
Watch Results against the 2026 guide, and further executive changes in 8-Ks.
Sources (10)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- Form 8-K, Item 8.01: Department of Justice criminal and civil requests on Medicare participation
- Q4 and full-year FY2024 earnings release (Form 8-K, Exhibit 99.1, Jan 16, 2025)
- Form 8-K, Item 1.05: Change Healthcare cybersecurity incident
- Form 10-K, fiscal year 2024 (ended Dec 31, 2024)
- Form 8-K, Items 5.02 and 7.01: CEO transition, 2025 outlook suspended (with Exhibit 99.1)
- Form 8-K, Item 5.02: CFO appointment (Exhibit 99.1, Jul 31, 2025)
- Form 8-K, Item 5.02: Optum CEO appointment
09Both sides
What do supporters and critics point to?
What supporters point to
- Revenue rose every year from FY2021 to FY2025, reaching $447.6 billion.
- The 2026 guide went from GAAP EPS above $17.10 in January to at least $19.50 on Oct 13, 2026.
- Q3 FY2026 net earnings were $4.1 billion, up 75.0% from a year earlier, and the medical care ratio was 88.4% against 89.9%.
- Optum Insight's operating margin was 23.4% in Q3 FY2026.
- Fee-based employer members rose from 21.5 million to 22.2 million between Dec 31, 2025 and Sep 30, 2026.
What critics point to
- Earnings from operations per $100 of revenue fell from $8.3 in FY2021 to $4.2 in FY2025, as the medical care ratio rose to 89.1%.
- Q3 FY2026 revenue was 0.4% lower than a year earlier, and its medical care ratio included $610 million of favorable reserve development.
- Moody's, S&P and Fitch outlooks moved from stable to negative between Dec 31, 2024 and Dec 31, 2025, as stated by the company.
- The company said on Jul 24, 2025 that it had begun complying with formal criminal and civil requests from the DOJ about its Medicare participation.
- FY2025 adjusted EPS was $16.35 against $13.23 as reported, and the adjusted measure leaves out amortization every year.
10What to watch next
What should you watch next at UnitedHealth?
Next event
Q4 and full-year FY2026 results
Date not announced yet.
The medical care ratio
It was 88.4% in Q3 FY2026. On Jul 16, 2026, the company guided to 88.1%, plus or minus 0.25 points, for full-year 2026.
FY2026 results against the guide
On Oct 13, 2026, the company guided to GAAP EPS of at least $19.50 and adjusted EPS of at least $20.50 for 2026.
Membership and the 2027 outlook
UnitedHealthcare membership was down 1.46 million by Sep 30, 2026, against a 2026 plan of 2.3 to 2.8 million. Management said on Oct 13, 2026 that it would give 2027 details in December.
Legal and regulatory updates
The DOJ requests on Medicare, the 2017 False Claims Act case and the IRS tax notices, in each 10-Q and 10-K.
11Key dates
What are the key dates for UnitedHealth?
| Event | Date | Source |
|---|---|---|
| 2027 outlook detailsManagement said on the Oct 13, 2026 call that it would give 2027 details in December. | Not yet stated | Q3 FY2026 earnings call prepared remarks (Oct 13, 2026; no Q&A) |
12Key facts
Key facts about UnitedHealth
- What does UnitedHealth Group do?
- UnitedHealth Group Incorporated runs UnitedHealthcare, a health insurer for employers, individuals, Medicare and Medicaid, and Optum, which delivers care, sells health data and technology services and manages drug benefits. UnitedHealthcare covered 48.3 million people at Sep 30, 2026. Revenue was $447.6 billion in FY2025.
- How does UnitedHealth Group make money?
- UnitedHealth Group's business model is collecting premiums and fees and paying for care: in FY2025, premiums were 78.7% of its $447.6 billion of revenue, products (mostly drugs) 11.9%, services 8.5% and investment and other income 0.9%. Medical costs took $70.16 of every $100 that came in, and $2.69 was left as net earnings.
- Who are UnitedHealth Group's customers?
- Employers, individuals, state Medicaid programs and the federal government pay UnitedHealth Group. Premiums from CMS, the federal Medicare and Medicaid agency, were 44% of UnitedHealth's revenue in FY2025, up from 40% in FY2024. Optum's outside customers, such as other health plans, paid $100.9 billion, 22.5% of revenue.
- Is UnitedHealth Group profitable?
- Yes. UnitedHealth Group's net earnings were $12.1 billion in FY2025, down from $22.4 billion in FY2023, and diluted EPS was $13.23. Q4 FY2025 EPS was $0.01 after $2.5 billion of restructuring and other charges. For the four quarters to Sep 30, 2026, net earnings were $15.9 billion (Cityfort calculation from the Q4 FY2025 and Q3 FY2026 earnings releases).
- What is UnitedHealth Group's revenue by segment?
- In FY2025, UnitedHealth Group's UnitedHealthcare segment had revenue of $344.9 billion, Optum Rx $154.7 billion, Optum Health $102.0 billion and Optum Insight $19.4 billion. Optum sells a lot to UnitedHealthcare, so $173.4 billion of business between segments is removed to reach total revenue of $447.6 billion.
- Who owns UnitedHealth Group?
- UnitedHealth Group has one class of common stock with one vote per share, and 896.0 million shares on Oct 30, 2026. Directors and executive officers held 0.19% at Apr 2, 2026. The 2026 proxy lists BlackRock with 7.99%, from a filing dated Feb 6, 2024. Filings show Vanguard Capital Management with 7.5% (Mar 31, 2026) and State Street with 5% (Jun 30, 2026).
- How much does UnitedHealthcare bring UnitedHealth Group?
- UnitedHealthcare, UnitedHealth Group's insurance segment, had FY2025 revenue of $344.9 billion and earnings from operations of $9.4 billion, a 2.7% margin. Medicare & Retirement brought $171.3 billion, Community & State (Medicaid) $94.4 billion and Employer & Individual $79.2 billion.
- How much does Optum Rx bring UnitedHealth Group?
- Optum Rx, UnitedHealth Group's pharmacy benefit manager, had FY2025 revenue of $154.7 billion and earnings from operations of $7.2 billion, up from $91.3 billion and $4.1 billion in FY2021. It handled 393 million adjusted prescriptions in Q3 FY2026.
- How much does Optum Health bring UnitedHealth Group?
- Optum Health, UnitedHealth Group's care delivery segment, had FY2025 revenue of $102.0 billion and an operating loss of $278 million, after $1.7 billion of restructuring and other charges. In the first nine months of 2026 it earned $3.07 billion from operations, on the segment grouping used from Jan 1, 2026.
- How much does Optum Insight bring UnitedHealth Group?
- Optum Insight, UnitedHealth Group's health data, technology and services segment, which includes Change Healthcare, had FY2025 revenue of $19.4 billion and earnings from operations of $2.6 billion, a 13.5% margin. Its Q3 FY2026 operating margin was 23.4%.
Sources (8)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- 2026 proxy statement (DEF 14A)
- Schedule 13G, Vanguard Capital Management LLC (event Mar 31, 2026)
- Schedule 13G, State Street Corporation (event Jun 30, 2026)
- Form 10-K, fiscal year 2023 (ended Dec 31, 2023)
Terms on this page
- Capital expenditures (capex)
- Customer concentration
- Debt-to-equity
- Earnings per share (EPS)
- EBITDA
- Free cash flow
- Market cap
- Net debt
- Net margin
- P/E ratio
Each explains the term in plain English, with the same number from other companies on Cityfort.
Go deeper
More detail from the same filings. Open any section.
13What it sells
13What it sells
What does UnitedHealth sell?
Medicare & Retirement ($171.3B revenue, FY2025)
UnitedHealthcare plans for people on Medicare: Medicare Advantage (8.4 million people at Dec 31, 2025), Medicare Supplement and Part D drug plans, with 10.4 million in Part D programs.
Community & State ($94.4B)
Medicaid plans run for states, for people with low incomes or disabilities. They covered 7.4 million people at Dec 31, 2025 and 6.7 million at Sep 30, 2026.
Employer & Individual ($79.2B)
Plans for employers and individuals. In risk-based plans UnitedHealthcare pays the claims (8.2 million people at Dec 31, 2025). In fee-based plans the employer pays the claims and UnitedHealthcare runs the plan for a fee (21.5 million).
Optum Health ($102.0B)
Care delivery: doctors, clinics and other care services. The FY2025 10-K says it served about 95 million consumers and works with more than 100 payer partners.
Optum Rx ($154.7B)
A pharmacy benefit manager (PBM): it runs drug coverage for health plans and employers, processes prescription claims and sells drugs. It handled 424 million adjusted prescriptions in Q4 FY2025.
Optum Insight ($19.4B)
Health data, technology and services, including Change Healthcare. From Jan 1, 2026 it also holds Optum Financial, including Optum Bank.
What it does
- Does: Collects premiums from members, employers and governments, and pays members' medical claims from them
- Does: Runs health plans for self-funded employers for a fee, without taking the claim cost
- Does: Employs clinicians and delivers care through Optum Health: nearly 165,000 clinical professionals at Dec 31, 2025
- Does: Manages drug benefits and fills prescriptions through Optum Rx
What it does not do
- Does not: Does not add segment revenue up to the total: Optum sold $168.0 billion of services and drugs to UnitedHealthcare in FY2025, and that is removed
- Does not: No longer runs its Brazil business: it completed the sale on Feb 6, 2024
- Does not: Does not name its competitors in its FY2025 10-K
14How the money flows
14How the money flows · FY2025
How does money flow through UnitedHealth?
Money in
- Premiums$352.2B
- Products (mostly drugs)$53.4B
- Services$38.0B
- Investment and other income$3.9B
The company
UnitedHealth
$447.6B came in
Money out
- Medical costs (care paid for members)$314.0B
- Operating costs$59.6B
- Cost of products sold$50.7B
- Depreciation and amortization$4.4B
- Interest and loss on selling subsidiaries$4.3B
- Income tax and noncontrolling holders' share$2.6B
- Net earnings attributable to UnitedHealth$12.1B
- Members, employers, states and CMS paid UnitedHealth $447.6 billion of revenue in FY2025, including $352.2 billion of premiums.
- Paying members' medical bills took $314.0 billion, 89.1% of premiums.
- Running the business took $59.6 billion, and the drugs and other products it sold cost $50.7 billion.
- Depreciation and amortization took $4.4 billion, leaving $19.0 billion of earnings from operations. Interest and a loss on selling subsidiaries took $4.3 billion.
- Tax took $1.9 billion, and owners of part-owned units took $751 million. UnitedHealth's shareholders were left with $12.1 billion.
15What it needs to run
15What it needs to run
What does UnitedHealth need to run?
People
More than 390,000 employees at Dec 31, 2025, including nearly 165,000 clinical professionals.
Government contracts
Medicare Advantage and Part D plans run under contracts with CMS, and Medicaid plans under state contracts. CMS premiums were 44% of FY2025 revenue.
Capital in regulated insurers
Regulators set capital levels for the insurance subsidiaries and limit the cash they can pass up to the parent. Of $25.8 billion of cash at Sep 30, 2026, $1.2 billion was available for general corporate use.
Technology and data
Spending on property, equipment and capitalized software was $3.6 billion in FY2025. Optum Insight, which includes Change Healthcare, sells data and technology services.
16Where growth could come from
16Where growth could come from
Where could UnitedHealth's growth come from?
UnitedHealth said on Oct 13, 2026 that it expects 2026 GAAP EPS of at least $19.50 and adjusted EPS of at least $20.50. On Jan 27, 2026 it had guided to 2026 revenue above $439.0 billion. On the Oct 13, 2026 call, management repeated a long-term EPS growth target of 13% to 16% a year.
Medical costs against premiums
WorkingMedical care ratio 88.4%, Q3 FY2026
The ratio was 88.4% in Q3 FY2026, against 89.9% a year earlier, and included $610 million of favorable reserve development. On Jul 16, 2026, the company guided to 88.1%, plus or minus 0.25 points, for full-year 2026.
Status: Working, on track against what the company said.
Fewer, repriced members
Working1.46 million fewer members, Dec 31, 2025 to Sep 30, 2026
On Jan 27, 2026, management said UnitedHealthcare's membership would shrink by 2.3 to 2.8 million in 2026. By Sep 30, 2026, it was down 1.46 million, to 48.3 million. Medicare Advantage fell by 840,000 and Medicaid by 685,000.
Status: Working, on track against what the company said.
Optum Health's recovery
Mixed$735 million earnings from operations, Q3 FY2026
Optum Health earned $735 million from operations in Q3 FY2026, a 3.2% margin, against $41 million a year earlier. Its revenue fell from $25.4 billion to $22.9 billion over the same period. Both figures use the 2026 segment grouping.
Status: Mixed, partly on track.
Optum Rx outside clients
Mixed393 million adjusted prescriptions, Q3 FY2026
Optum Rx revenue was $39.9 billion in Q3 FY2026, against $39.7 billion a year earlier, while adjusted prescriptions fell from 414 million to 393 million. Management said on Oct 13, 2026 that over 50% of Optum Rx membership is outside UnitedHealthcare.
Status: Mixed, partly on track.
Medicare star ratings
EarlyAbout 75% of members in 4-star plans, management's aim
Management said on Oct 13, 2026 that it expects to approach 75% of members in plans rated 4 stars or more as it moves through 2027 into 2028. It cited an industry average of 70%. Star ratings decide Medicare bonus payments.
Status: Early, too early to judge.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
Sources (7)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Q3 FY2026 earnings call prepared remarks (Oct 13, 2026; no Q&A)
- Q2 FY2026 earnings release (Form 8-K, Exhibit 99.1, Jul 16, 2026)
- Q3 FY2025 earnings release (Form 8-K, Exhibit 99.1, Oct 28, 2025)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Q4 FY2025 earnings call prepared remarks (Jan 27, 2026; no Q&A)
17The company's own measures (non-GAAP)
17The company's own measures · FY2022 to FY2025, and Q3 FY2026 (quarter ended Sep 30, 2026)
What do UnitedHealth's own measures show?
Official (GAAP): Diluted EPS, FY2025
$13.23
Company's own measure: Adjusted EPS, FY2025
$16.35
UnitedHealth leaves out $1.6 billion of intangible amortization, $2.5 billion of restructuring and other charges and $799 million of cyberattack costs, and takes out a $442 million net gain from portfolio sales and South American items, all before tax.
Official (GAAP): Earnings from operations, FY2025
$19.0B
Company's own measure: Adjusted earnings from operations, FY2025
$21.7B
Same definition, before interest and tax. By segment: UnitedHealthcare $9.6 billion, Optum Rx $6.1 billion, Optum Insight $3.7 billion and Optum Health $2.3 billion.
Official (GAAP): Diluted EPS, FY2024
$15.51
Company's own measure: Adjusted EPS, FY2024
$27.66
Leaves out $8.5 billion of South American impacts, including the Brazil sale loss, $2.2 billion of direct cyberattack response costs and $1.7 billion of amortization. It keeps $867 million of business disruption from the cyberattack.
Official (GAAP): Diluted EPS, FY2022
$21.18
Company's own measure: Adjusted EPS, FY2022
$22.19
Mainly leaves out intangible amortization, which the company excludes every year.
Official (GAAP): Diluted EPS, Q3 FY2026
$4.56
Company's own measure: Adjusted EPS, Q3 FY2026
$4.69
Same definition. A year earlier, adjusted EPS was $2.92 and diluted EPS $2.59.
Official (GAAP): Medical costs, Q3 FY2026
76,982.0%
Company's own measure: Medical care ratio, Q3 FY2026
88.4%
The company's measure: medical costs ÷ premiums ($87.1 billion in the quarter). It was 89.9% a year earlier, 89.1% for FY2025 and 85.5% for FY2024.
Official (GAAP): Total debt, Sep 30, 2026
74,331.0%
Company's own measure: Debt-to-capital ratio, Sep 30, 2026
41.7%
As stated by the company; the company said on Oct 13, 2026 that it targets about 40% by year-end. It was 44.1% a year earlier.
These are the company's own measures, defined by the company. They are not comparable across companies, and they are not added together. Each sits beside the nearest official (GAAP) figure.
Learn: Non-GAAP measures: what a company's "adjusted" numbers leave out
Sources (8)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Q4 and full-year FY2024 earnings release (Form 8-K, Exhibit 99.1, Jan 16, 2025)
- Form 10-K, fiscal year 2023 (ended Dec 31, 2023)
- Q4 and full-year FY2022 earnings release (Form 8-K, Exhibit 99.1, Jan 13, 2023)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Q3 FY2025 earnings release (Form 8-K, Exhibit 99.1, Oct 28, 2025)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
18Financial strength and debt
18Financial strength · Sep 30, 2026
How much debt does UnitedHealth have?
- Total debt$74.3B
- Cash and investments$25.8B
- Net debt (debt minus cash)$48.5B
- Net worth (shareholders' money)$98.1B
- Debt to equity
- 0.76×
- $ of debt for every $1 of shareholders' money
- Debt includes commercial paper and current maturities, not operating leases. It fell from $78.4 billion at Dec 31, 2025.
- Cash here leaves out $2.7 billion of short-term investments at Sep 30, 2026. Of the $25.8 billion of cash at that date, $1.2 billion was available for general corporate use.
- Net worth is UnitedHealth shareholders' equity; total equity including noncontrolling interests was $104.1 billion.
- Goodwill was $113.0 billion, 36% of total assets of $312.8 billion at Sep 30, 2026 (Cityfort calculation from the Q3 FY2026 10-Q).
- The company has three $7.0 billion bank credit lines with 26 banks.
19Who owns it
19Who owns it · ownership as of Apr 2, 2026
Who owns UnitedHealth?
- Officers and directors (as a group), shares
- 0.2%
Share classes
Holders of 5% or more
From the company's proxy statement (DEF 14A), later Schedule 13G filings and the share counts on its latest annual or quarterly report. Each holder row shows the date of its own filing.
Learn: How to read a proxy statement (DEF 14A): Nvidia's 2026 proxy · Form 4 insider filings: who files, the codes and the footnotes
Sources (7)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- 2026 proxy statement (DEF 14A)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Schedule 13G/A, The Vanguard Group (event Apr 30, 2025)
- Schedule 13G/A, The Vanguard Group (event Mar 13, 2026: no longer reports beneficial ownership)
- Schedule 13G, Vanguard Capital Management LLC (event Mar 31, 2026)
- Schedule 13G, State Street Corporation (event Jun 30, 2026)
20What it does with profit
20What it does with profit
What does UnitedHealth do with its profit?
Dividend per share
$8.73FY2025
Dividend paid for each share, by financial year.
$ per share
See the numbers
Buyback · Dec 31, 2021
FY2021: paid $5.0 billion for its own shares.
$5.0B
Buyback · Dec 31, 2022
FY2022: paid $7.0 billion for its own shares.
$7.0B
Buyback · Dec 31, 2023
FY2023: paid $8.0 billion for its own shares.
$8.0B
Buyback · Dec 31, 2024
FY2024: paid $9.0 billion for its own shares.
$9.0B
Buyback · Dec 31, 2025
FY2025: paid $5.5 billion for its own shares.
$5.5B
21Governance signals
21Governance signals
What do UnitedHealth's governance filings show?
- Auditor
- Deloitte & Touche LLP, since 2002
- Auditor changes
- None in the period covered
- Audit qualifications
- None reported
- Related-party dealings
- The 2026 proxy describes a written policy: transactions over $120,000 with directors, executive officers or 5% holders are prohibited unless the board's Governance Committee approves or ratifies them. Its related-person section names no such transactions.
- Credit rating
- Moody's, S&P, Fitch and A.M. Best (as stated by UnitedHealth) A2 / A+ / A / A- (Negative (Moody's, S&P, Fitch), stable (A.M. Best)), Sep 30, 2026
A credit rating describes the company's ability to repay debt. It is not a rating of the share.
Flags to know about
regulatory
Department of Justice requests on Medicare
UnitedHealth disclosed on Jul 24, 2025 that it is complying with formal criminal and civil requests from the Department of Justice about its participation in Medicare. The filings collected give no later update on these requests.
regulatory
False Claims Act case on Medicare risk adjustment
A Department of Justice case about Medicare Advantage risk adjustment has run since 2017. In March 2025 a court-appointed Special Master recommended judgment for the company, and in April 2025 the DOJ asked the court to reject that. The company says it cannot estimate the outcome.
regulatory
IRS proposed tax adjustments
On Mar 6, 2026, the IRS issued notices of proposed adjustment on 2017 to 2020 transfer pricing with a foreign subsidiary. The company says it disagrees.
other
Change Healthcare cyberattack
On Feb 21, 2024, the company found a cyberattack on Change Healthcare by what it called a suspected nation-state associated actor. It lent care providers $9.0 billion interest-free in 2024 and recorded a $799 million reserve on those loans in Q4 FY2025.
other
Chair and CEO are the same person
Stephen Hemsley has been Chair and CEO since May 2025. The board says it does not intend to keep the roles combined indefinitely. An independent-chair shareholder proposal got 20.24% support on Jun 1, 2026 and failed.
other
Pay votes and leadership changes
Shareholders backed executive pay with 60% at the 2025 meeting and 82.74% on Jun 1, 2026. The CEO, Optum CEO and CFO all changed in 2025, and Scott Gottlieb, a former FDA commissioner, joined the board in November 2025. The 2023 to 2025 long-term incentive plan paid 0%.
shares as collateral
UnitedHealth stock as loan collateral
The insider trading policy bars directors and executive officers from hedging UnitedHealth stock or using it as collateral for loans. The 2026 proxy discloses no such arrangements.
disclosure
What UnitedHealth does not report
It gives no revenue by customer other than CMS, no split of Medicaid money between states and the federal government, and no Optum Rx client names. It did not name the business it bought on Jul 2, 2026 for $3.0 billion. It has not published FY2025 segment totals on the 2026 grouping, and it posts call remarks without the question-and-answer part.
Sources (13)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- 2026 proxy statement (DEF 14A)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- Form 8-K, Item 8.01: Department of Justice criminal and civil requests on Medicare participation
- EDGAR company submissions for UnitedHealth Group (CIK 0000731766)
- Form 8-K, Item 1.05: Change Healthcare cybersecurity incident
- Form 8-K, Item 5.07: 2026 annual meeting vote results
- Form 8-K, Items 5.02 and 7.01: CEO transition, 2025 outlook suspended (with Exhibit 99.1)
- Form 8-K, Item 5.02: CFO appointment (Exhibit 99.1, Jul 31, 2025)
- Form 8-K, Item 5.02: Optum CEO appointment
- Form 8-K, Item 5.02: Scott Gottlieb appointed director
- Q3 FY2026 earnings call prepared remarks (Oct 13, 2026; no Q&A)
- Q4 FY2025 earnings call prepared remarks (Jan 27, 2026; no Q&A)
22What the market paid
22What the market paid · price as of Nov 5, 2026
What did the market pay for UnitedHealth on Nov 5, 2026?
Price as of Nov 5, 2026 (shown for education; prices change daily).
Price as of Nov 5, 2026: $395.72, the close shown in Nasdaq's historical price table for UnitedHealth; the shares list on the NYSE, and this price is from Nasdaq's site, not NYSE's. Times 896.0 million shares (Oct 30, 2026), that is a market value of about $354.6 billion (Cityfort calculation from the Nov 5, 2026 closing price and the Q3 FY2026 10-Q cover). P/E is price ÷ earnings per share: 22.6 on diluted EPS of $17.51 for the four quarters to Sep 30, 2026 (Cityfort calculation from the Q4 FY2025 and Q3 FY2026 earnings releases). That EPS includes Q4 FY2025 at $0.01 after restructuring and other charges. Price to book is 3.61 on UnitedHealth shareholders' equity of $98.1 billion at Sep 30, 2026. The $9.28 annual dividend rate set in June 2026 is 2.35% of this price.
- Share price
- $395.72
- Market value (market cap)
- $354.6B
- P/E
- 22.6×
- P/B
- 3.6×
More price-based ratios · as of Nov 5, 2026
Each ratio divides a number from the company's filings by the market value or share price on Nov 5, 2026. Prices change daily, so these ratios do too.
Price to sales (P/S)
0.8×
$354.6B market value ÷ $449.7B revenue (four quarters to Sep 30, 2026) = 0.8×
Cityfort calculation from the Nov 5, 2026 closing price and the Q4 FY2025 to Q3 FY2026 earnings releases. Source: Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026; Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026); Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026) and 3 more
How price ratios workDividend yield
2.21%
$8.73 dividends per share (FY2025) ÷ $395.72 share price = 2.21%
Cityfort calculation from the FY2025 10-K and the Nov 5, 2026 closing price. Source: Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026; Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026); Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026) and 2 more
What dividend yield meansFree cash flow yield
4.5%
$16.1B free cash flow (FY2025) ÷ $354.6B market value = 4.5%
Cityfort calculation from the FY2025 10-K and the Nov 5, 2026 closing price. Source: Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026; Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026); Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026) and 2 more
What free cash flow means
Shares used for the market value: 896 million ($395.72 × 896 million shares ≈ $354.6B). Source: Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026); 2026 proxy statement (DEF 14A); Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
Source: Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026; Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026); Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026) and 1 more
Sources (8)
- Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Q1 FY2026 earnings release (Form 8-K, Exhibit 99.1, Apr 21, 2026)
- Q2 FY2026 earnings release (Form 8-K, Exhibit 99.1, Jul 16, 2026)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- 2026 proxy statement (DEF 14A)
23How it got here
23How it got here
How did UnitedHealth get here?
2024
Business-model change
Brazil business sold
The sale closed on Feb 6, 2024. FY2024 carried an $8.3 billion loss on selling subsidiaries, including $7.1 billion on Brazil, of which $4.1 billion was currency translation.
2024
Crisis
Change Healthcare cyberattack
Found on Feb 21, 2024. UnitedHealth lent care providers $9.0 billion interest-free that year.
2025
Crisis
Guidance cut, CEO change, outlook suspended
The 2025 adjusted EPS guide was cut on Apr 17, 2025. On May 12, Andrew Witty stepped down and Chair Stephen Hemsley became CEO; the change was announced and the 2025 outlook suspended on May 13.
2025
Crisis
Department of Justice requests disclosed
On Jul 24, 2025, the company said it is complying with formal criminal and civil requests about its Medicare participation.
2025
Milestone
Outlook reinstated, new CFO
On Jul 29, 2025, the company guided to 2025 adjusted EPS of at least $16.00. Wayne DeVeydt became CFO on Sep 2, 2025.
2025
Crisis
Q4 charges
Q4 FY2025 carried $2.5 billion of restructuring and other charges and a $799 million cyberattack loan reserve. Q4 EPS was $0.01.
2026
Business-model change
Segments regrouped
On Jan 1, 2026, Optum Financial, including Optum Bank, moved from Optum Health to Optum Insight.
2026
Milestone
$3.0 billion acquisition
On Jul 2, 2026, the company completed an acquisition for $3.0 billion: $1.5 billion in cash and $1.5 billion payable within a year. The 10-Q does not name the business.
2026
Milestone
2026 outlook raised three times
The 2026 adjusted EPS guide went from above $17.75 on Jan 27 to at least $20.50 on Oct 13, 2026.
Sources (11)
- Form 10-K, fiscal year 2025 (ended Dec 31, 2025)
- Form 10-K, fiscal year 2024 (ended Dec 31, 2024)
- Form 8-K, Item 1.05: Change Healthcare cybersecurity incident
- Q1 FY2025 earnings release (Form 8-K, Exhibit 99.1, Apr 17, 2025)
- Form 8-K, Items 5.02 and 7.01: CEO transition, 2025 outlook suspended (with Exhibit 99.1)
- Form 8-K, Item 8.01: Department of Justice criminal and civil requests on Medicare participation
- Q2 FY2025 earnings release (Form 8-K, Exhibit 99.1, Jul 29, 2025)
- Form 8-K, Item 5.02: CFO appointment (Exhibit 99.1, Jul 31, 2025)
- Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026)
- Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026)
- Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026)
24Sources and changes
Where every number on this page comes from
Sources (31 documents)
- S1Form 10-K, fiscal year 2025 (ended Dec 31, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Mar 2, 2026
- S2Form 10-K, fiscal year 2024 (ended Dec 31, 2024) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Feb 27, 2025
- S3Form 10-K, fiscal year 2023 (ended Dec 31, 2023) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Feb 28, 2024
- S5Form 10-Q, Q3 FY2026 (quarter ended Sep 30, 2026) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Nov 3, 2026
- S6Q3 FY2026 earnings release (Form 8-K, Exhibit 99.1, Oct 13, 2026) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Oct 13, 2026
- S7Q2 FY2026 earnings release (Form 8-K, Exhibit 99.1, Jul 16, 2026) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jul 16, 2026
- S8Q1 FY2026 earnings release (Form 8-K, Exhibit 99.1, Apr 21, 2026) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Apr 21, 2026
- S9Q4 and full-year FY2025 earnings release (Form 8-K, Exhibit 99.1, Jan 27, 2026) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jan 27, 2026
- S10Q3 FY2025 earnings release (Form 8-K, Exhibit 99.1, Oct 28, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Oct 28, 2025
- S11Q2 FY2025 earnings release (Form 8-K, Exhibit 99.1, Jul 29, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jul 29, 2025
- S12Q1 FY2025 earnings release (Form 8-K, Exhibit 99.1, Apr 17, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Apr 17, 2025
- S13Q4 and full-year FY2024 earnings release (Form 8-K, Exhibit 99.1, Jan 16, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jan 16, 2025
- S14Q3 FY2024 earnings release (Form 8-K, Exhibit 99.1, Oct 15, 2024) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Oct 15, 2024
- S15Q4 and full-year FY2022 earnings release (Form 8-K, Exhibit 99.1, Jan 13, 2023) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jan 13, 2023
- S162026 proxy statement (DEF 14A) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Apr 21, 2026
- S17Form 8-K, Item 5.07: 2026 annual meeting vote results · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jun 5, 2026
- S18Schedule 13G/A, The Vanguard Group (event Apr 30, 2025) · The Vanguard Group (SEC EDGAR) · Tier 1: company or exchange filing · May 7, 2025
- S19Schedule 13G/A, The Vanguard Group (event Mar 13, 2026: no longer reports beneficial ownership) · The Vanguard Group (SEC EDGAR) · Tier 1: company or exchange filing · Mar 27, 2026
- S20Schedule 13G, Vanguard Capital Management LLC (event Mar 31, 2026) · Vanguard Capital Management LLC (SEC EDGAR) · Tier 1: company or exchange filing · Apr 30, 2026
- S21Schedule 13G, State Street Corporation (event Jun 30, 2026) · State Street Corporation (SEC EDGAR) · Tier 1: company or exchange filing · Aug 7, 2026
- S22Form 8-K, Item 1.05: Change Healthcare cybersecurity incident · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Feb 22, 2024
- S23Form 8-K, Items 5.02 and 7.01: CEO transition, 2025 outlook suspended (with Exhibit 99.1) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · May 14, 2025
- S24Form 8-K, Item 8.01: Department of Justice criminal and civil requests on Medicare participation · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jul 24, 2025
- S25Form 8-K, Item 5.02: CFO appointment (Exhibit 99.1, Jul 31, 2025) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Jul 31, 2025
- S26Form 8-K, Item 5.02: Optum CEO appointment · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Apr 29, 2025
- S27Form 8-K, Item 5.02: Scott Gottlieb appointed director · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Nov 21, 2025
- S28Form 8-K, Item 5.02: CEO stock option amended (holding requirement) · UnitedHealth Group Incorporated (SEC EDGAR) · Tier 1: company or exchange filing · Feb 25, 2026
- S29Q3 FY2026 earnings call prepared remarks (Oct 13, 2026; no Q&A) · UnitedHealth Group Incorporated (investor relations) · Tier 1: company or exchange filing · Oct 13, 2026
- S30Q4 FY2025 earnings call prepared remarks (Jan 27, 2026; no Q&A) · UnitedHealth Group Incorporated (investor relations) · Tier 1: company or exchange filing · Jan 27, 2026
- S31Nasdaq historical price table for UNH (NYSE-listed), close Nov 5, 2026 · Nasdaq, Inc. · Tier 1: company or exchange filing · Nov 6, 2026
- S32EDGAR company submissions for UnitedHealth Group (CIK 0000731766) · SEC EDGAR · Tier 1: company or exchange filing · Nov 6, 2026
Changes to this page (v1 · Nov 6, 2026)
- v1 · Nov 6, 2026First version, through Q3 FY2026 (quarter ended Sep 30, 2026). (first version)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.
Read the positions policyRead the full disclaimerHide the full disclaimer
Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.
All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.